Current Liabilities

Short-Term Borrowings

AbbVie Short-Term Borrowings decreased by 34.1% to $2.50B in Q4 2025 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 136.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.

Detailed definition

Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...

Peer comparison

Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.

Metric ID: short_term_borrowings

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$17.00M$16.00M$14.00M$12.00M$17.00M$10.00M$1.00M$1.00M$0.00$2.00M$0.00$3.00M$0.00$1.59B$5.56B$3.79B$2.50B
QoQ Change-5.9%-12.5%-14.3%+41.7%-41.2%-90.0%+0.0%-100.0%-100.0%-100.0%+248.8%-31.8%-34.1%
YoY Change+0.0%-37.5%-92.9%-91.7%-100.0%-80.0%-100.0%+200.0%>999%
Range$0.00$5.56B
CAGR+248.2%
Avg YoY Growth>999%
Median YoY Growth-80.0%
Current Streak2 quarters decline

Short-Term Borrowings at Other Companies

Frequently Asked Questions

What is AbbVie's short-term borrowings?
AbbVie (ABBV) reported short-term borrowings of $2.50B in Q4 2025.
What is the long-term trend for AbbVie's short-term borrowings?
Over 5 years (2020 to 2025), AbbVie's short-term borrowings has grown at a 136.2% compound annual growth rate (CAGR), from $34.00M to $2.50B.
What does short-term borrowings mean?
Debt that must be repaid within the next twelve months.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.